A novel liquid biopsy-based approach for highly specific cancer diagnostics: mitigating false responses in assaying patient plasma-derived circulating microRNAs through combined SERS and plasmon-enhanced fluorescence analyses
Keyword(s):
Novel multimodal assay has been developed to quantify circulating microRNAs through a combined surface-enhanced Raman scattering and plasmon-enhanced fluorescence approach.
2011 ◽
Vol 400
(2)
◽
pp. 361-367
◽
2021 ◽